[Protective effects of mexiletine on reperfused ischemic myocardium].
Tanaka
T
T
Suzuki
T
T
Sunamori
M
M
Suzuki
A
A
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002314:Cardioplegic Solutions / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008801:Mexiletine / Q000494:pharmacology*; D015425:Myocardial Reperfusion; D009206:Myocardium / Q000378:metabolism* / Q000648:ultrastructure; D019188:Organ Preservation Solutions / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014325:Tromethamine / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D002314:Cardioplegic Solutions; C074097:Krebs-Henseleit solution; D019188:Organ Preservation Solutions; D014325:Tromethamine; D008801:Mexiletine; D005947:Glucose